If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBarr (A.G.) Regulatory News (BAG)

Share Price Information for Barr (A.G.) (BAG)

Share Price is delayed by 15 minutes
Get Live Data
638.00    -3.00 (-0.47%)
Bid:
638.00
Ask:
639.00
Spread: 1.00 (0.157%)
Market Cap: £708.02m
BAG Live PriceLast checked at - London Stock Exchange

Intraday Barr (A.G.) Share Chart

Directorate changes announcement

26 Mar 2024 07:00

RNS Number : 2331I
Barr(A.G.) PLC
26 March 2024
 

IMMEDIATE RELEASE 26 March 2024

 

A.G. BARR p.l.c.

("A.G. BARR" or the "Company")

 

A.G. BARR is a branded multi-beverage business with a portfolio of market-leading UK brands, including IRN-BRU, Rubicon, FUNKIN and Boost.

 

Directorate changes announcement

 

The Board of Directors (Board) of A.G. BARR p.l.c. announces that Jonathan Kemp has advised the Board that, owing to family health reasons, he will not seek re-election as a statutory director of the Company at its Annual General Meeting scheduled to take place on 31 May 2024 (AGM) and will retire as a director of the Company following conclusion of the AGM. In order to facilitate a smooth leadership transition, Jonathan will continue to lead the Commercial function until 30 September 2024. Thereafter he will remain available to the Company as required for a further twelve month period following which he will retire from the business. The business will commence a recruitment process in due course to identify a successor - this role will not be an executive director Board position.

 

As previously communicated on 26 May 2023, after nine years as a Non-Executive Director, David Ritchie will stand down from the Board with effect from the conclusion of the AGM. David will be succeeded by Louise Smalley as Remuneration Committee Chair.

 

Mark Allen, Chair of A.G. BARR, commented "On behalf of the Board, I would like to thank Jonathan for his significant contribution to A.G. BARR for over 20 years. As Commercial Director, he has been instrumental to the growth of the Company, with the business in a strong position to continue to grow and develop. We wish him and his family all the very best for the future. I would also like to thank David for his commitment and contribution to the business over many years. The Board has benefitted from his extensive knowledge and experience and wishes him well with his future endeavours."

 

For more information, please contact:

 

A.G. BARR 0330 390 3900

Mark Allen, Chair

Instinctif Partners  020 7457 2020

Justine Warren

Matthew Smallwood

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABIGDXBXDDGSU
Date   Source Headline
8th Sep 20222:08 pmRNSDirector/PDMR Shareholding
31st Aug 202210:29 amRNSNotice of Interim Results Date
8th Aug 20221:05 pmRNSDirector/PDMR Shareholding
2nd Aug 20227:00 amRNSTrading Update
11th Jul 202210:32 amRNSDirector/PDMR Shareholding
16th Jun 202210:14 amRNSDirector/PDMR Shareholding
16th Jun 202210:04 amRNSDirector/PDMR Shareholding
15th Jun 202210:23 amRNSDirector/PDMR Shareholding
13th Jun 20221:42 pmRNSDirector/PDMR Shareholding
13th Jun 20221:40 pmRNSDirector/PDMR Shareholding
8th Jun 20229:53 amRNSDirectorship
27th May 20221:55 pmRNSResult of AGM
23rd May 20229:55 amRNSDirector/PDMR Shareholding
11th May 20228:53 amRNSDirector/PDMR Shareholding
26th Apr 20229:08 amRNSAnnual Financial Report / Notice of AGM
11th Apr 20221:11 pmRNSDirector/PDMR Shareholding
11th Apr 20228:51 amRNSDirector/PDMR Shareholding
11th Apr 20228:45 amRNSDirector/PDMR Shareholding
30th Mar 20227:00 amRNSDirectorate Change
29th Mar 20222:34 pmRNSDirector/PDMR Shareholding
29th Mar 20229:37 amRNSCorrection: Final results year ended 30 Jan 2022
29th Mar 20227:00 amRNSFinal results for the year ended 30 January 2022
18th Mar 20229:02 amRNSHolding(s) in Company
8th Mar 20222:14 pmRNSDirector/PDMR Shareholding
9th Feb 20227:56 amRNSDirector/PDMR Shareholding
4th Feb 20228:32 amRNSHolding(s) in Company
4th Feb 20228:27 amRNSHolding(s) in Company
1st Feb 20227:00 amRNSTrading Update
26th Jan 202210:35 amRNSNotice of Trading Update
11th Jan 202211:28 amRNSDirector/PDMR Shareholding
8th Dec 202112:59 pmRNSDirector/PDMR Shareholding
6th Dec 20217:00 amRNSInvestment in MOMA Foods Limited
29th Nov 20217:00 amRNSTrading Update
8th Nov 20212:15 pmRNSDirector/PDMR Shareholding
3rd Nov 20211:21 pmRNSDirector/PDMR Shareholding
3rd Nov 20219:37 amRNSDirector/PDMR Shareholding
1st Nov 202112:50 pmRNSDirector/PDMR Shareholding
11th Oct 20212:15 pmRNSDirector/PDMR Shareholding
11th Oct 20218:12 amRNSDirector/PDMR Shareholding
1st Oct 20218:49 amRNSDirector/PDMR Shareholding
1st Oct 20218:33 amRNSDirector/PDMR Shareholding
28th Sep 20217:00 amRNSInterim results
8th Sep 202111:39 amRNSDirector/PDMR Shareholding
31st Aug 202110:37 amRNSNotice of Interim Results Date
9th Aug 202111:21 amRNSDirector/PDMR Shareholding
3rd Aug 20217:00 amRNSH1 trading update to 1 August 2021
20th Jul 20217:00 amRNSTrading Update
19th Jul 20212:22 pmRNSHolding(s) in Company
9th Jul 20217:55 amRNSDirector/PDMR Shareholding
6th Jul 20213:32 pmRNSDirector/PDMR Shareholding - AMENDMENT

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.